Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-329186
Filing Date
2025-12-23
Accepted
2025-12-22 20:11:51
Documents
4
Period of Report
2025-12-22

Document Format Files

Seq Description Document Type Size
1 6-K d93446d6k.htm 6-K 9926
2 EX-99.1 d93446dex991.htm EX-99.1 16841
3 GRAPHIC g93446g1222222808082.jpg GRAPHIC 4955
4 GRAPHIC g93446g1222222808249.jpg GRAPHIC 1188
  Complete submission text file 0001193125-25-329186.txt   36750
Mailing Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000
Business Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000 612 8315 7003
IMMUTEP Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 251593944
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)